Tumour model

Panc02-H7

Adenocarcinoma
SyngeneicIn vitro

Antineo Pancreas Adenocarcinoma tumour model – Panc02H7

Panc02H7 cells

Mouse Panc02H7 cells were isolated from tumors obtained after multiple passages of liver
micrometastases following tumor implantation of Panc02 cells in mice. This model is more aggressive
than the parental Panc02 model.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of
C57bl/6 mice. The resulting tumours were monitored by measuring two diameters with calipers, and
extrapolating the volume to a sphere.
The mice bearing Panc02H7 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral
or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (View PDF)
Tumour growth curve of the Panc02H7 cells as subcutaneous tumors Mean ± SEM (n=6; take rate 100%)

Download PDF

Model characteristics

Organism
Mouse
Tissue of origin
Pancreas
Pathology
Adenocarcinoma
Model type
In vitro, Syngeneic
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Pancreas
Cystic fibrosis, Pancreatic ductal adenocarcinoma
XenograftIn vitro
Human
Pancreas
Adenocarcinoma
XenograftIn vitro
Human
Pancreas
Adenocarcinoma - PDAC
XenograftIn vitro
Human
Pancreas
Adenocarcinoma
XenograftIn vitro
Human
Pancreas
Adenocarcinoma
XenograftIn vitro
Human
Pancreas
Pancreatic ductal adenocarcinoma
XenograftIn vitro